Effects of gamma linolenic acid and arachidonic acid on cell cycle progression and apoptosis induction in normal and transformed cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 4, 1997, Pages 271-280

  Seegers, J C ^a   De Kock, M ^a   Lottering, M L ^a   Grobler, C J S ^a   Van Papendorp, D H ^a   Shou, Y ^b   Habbersett, R ^b   Lehnert, B E ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; GAMMA LINOLENIC ACID; PROTEIN P53; VIRUS LARGE T ANTIGEN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMPARISON; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOBLAST; PRIORITY JOURNAL; SKIN FIBROBLAST;

EID: 0030905108     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90570-6     Document Type: Article

References (34)

1. De Kock M., Seegers J. C., Els H. J. Effects of gamma-linolenic acid on mitosis and nuclear morphology in osteogenic sarcoma cells. S Afr Med J 1992; 81: 467-472.
2. De Kock M., Lottering M. L., Seegers J. C. Differential cytotoxic effects of gamma-linolenic acid on MG-63 and HeLa cells. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 109-120.
3. Begin M. E., Das U. N., Ells G., Horrobin D. F. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med 1985; 19: 177-186.
4. Begin M. E., Ells G., Das U. N., Horrobin D. F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 1986; 77: 1053-1062.
5. Jayadev S., Linardic C. M., Hannun Y. A. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem 1994; 269: 5757-5763.
6. Jarvis W. D., Fornari F. A., Jr., Browning J. L., Gewirtz D. A., Kolesnick R. N., Grant S. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 1994; 269: 31685-31692.
7. Hayakawa M., Ishida N., Takeuchi K. et al. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993; 268: 11290-11295.
8. Zurier R. B., Baker D. G., DeMarco D. et al. In: Horrobin D. F., ed. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. 15, Anti-inflammatory effects of gamma-linolenic acid: Studies in animals and in cultured cells. New York: Wiley-Liss, 1990: 203-221.
9. Horrobin D. F. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. 27, Essential fatty acids, lipid peroxidation and cancer. New York: Wiley-Liss, 1990: 351-377.
10. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51(23 Pt 1): 6304-6311.
11. Clarke A. R., Purdie C. A., Harrison D. J. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways [see comments]. Nature 1993; 362: 849-852.
12. De Kock M., Lottering M. L., Seegers J. C. AA and GLA. Prostaglandins Leukot Essent Fatty Acids 1996;
13. Ray F. A., Peabody D. S., Cooper J. L., Cram L. S., Kraemer P. M. SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 1990; 42: 13-31.
14. Ray F. A., Kraemer P. M. Frequent deletions in nine newly immortal human cell lines. Cancer Genet Cytogenet 1992; 59: 39-44.
15. Amundson S. A., Xia F., Wolfson K., Liber H. L. Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor. Mutat Res 1993; 286: 233-241.
16. Little J. B., Nagasawa H., Keng P. C., Yu Y., Li C. Y. Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J Biol Chem 1995; 270: 11033-11036.
17. McCormick F., Clark R., Harlow E., Tjian R. SV40 T antigen binds specifically to a cellular 53 K protein in vitro. Nature 1981; 292: 63-65.
18. Seegers J. C., Lottering M. L., Habbersett R. C., Shou Y., Lehnert B. E. The endogenous mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction selectively in normal and transformed cells with different p53 status. Cancer Res 1996;
19. Columbano A. Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 1995; 58: 181-190.
20. Jiang W. G., Hiscox S., Hallett M. B., Scott C., Horrobin D. F., Puntis M. C. Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer 1995; 71: 744-752.
21. Das U. N., Prasad V. V., Reddy D. R. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 1995; 94: 147-155.
22. Rose D. P., Hatala M. A., Connolly J. M., Rayburn J. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res 1993; 53: 4686-4690.
23. Noguchi M., Rose D. P., Earashi M., Miyazaki I. The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. [Review]. Oncology 1995; 52: 265-271.
24. Hannun Y. A. The sphingomyelin cycle and the second messenger function of ceramide. [Review]. J Biol Chem 1994; 269: 31251-3128.
25. Obeid L. M., Hannun Y. A. Ceramide: A stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 1995; 58: 191-198.
26. Lane D. P. Cancer. p53, guardian of the genome [news; comment] [see comments]. Nature 1992; 358: 15-16.
27. Meikrantz W., Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995; 58: 160-174.
28. Nigg E. A. Targets of cyclin-dependent protein kinases. [Review]. Curr Opin Cell Biol 1993; 5: 187-193.
29. Meikrantz W., Gisselbrecht S., Tam S. W., Schlegel R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 1994; 91: 3754-3758.
30. Kirstein M., Fiers W., Baglioni C. Growth inhibition and cytotoxicity of tumor necrosis factor in L929 cells is enhanced by high cell density and inhibition of mRNA synthesis. J Immunol 1986; 137: 2277-2280.
31. van de Loosdrecht A., Ossenkoppele G. J., Beelen R. H., Broekhoven M. G., Langenhuijsen M. M. Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins. Cancer Res 1993; 53: 4399-4407.
32. Brown D. M., Warner G. L., Ales-Martinez J. E., Scott D. W., Phipps R. P. Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Clin Immunol Immunopathol 1992; 63: 221-229.
33. Pica F., Franzese O., D'Onofrio C., Paganini L, Favalli C., Bonmassar E., Garaci E. Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. Adv Prostaglandin Thromboxane Leukot Res 1995; 23: 457-459.
34. Kerr J. F. R., Harmon B. V., Momei L. D., Cape F. O., eds. Current Communications 3. Cell and Molecular biology. Definition and incidence of apoptosis: a historical perspective. New York: Cold Spring Harbor Laboratory Press, 1991: 5.